PharmaEngine Inc operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares PharmaEngine Inc with three other
companies in this sector in Taiwan:
Medigen Biotechnology Corporation
sales of 399.89 million Taiwanese Dollars [US$13.53 million]
of which 81%
was Drug Discovery),
Sofiva Genomics Co Ltd
(383.95 million Taiwanese Dollars [US$12.99 million]
Unicocell Biomed Co Ltd
(1.00 billion Taiwanese Dollars [US$33.94 million]
During the year ended December of 2016, sales at
PharmaEngine Inc were 1.13 billion Taiwanese Dollars (US$38.40 million).
increase of 123.7%
versus 2015, when the company's sales were 507.24 million Taiwanese Dollars.
This was the third consecutive year of growth at PharmaEngine Inc.